Additional file 2 of Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients

  • Hitoshi Kawasuji (作成者)
  • Yasuhiro Tsuji (作成者)
  • Chika Ogami (作成者)
  • Kou Kimoto (作成者)
  • Akitoshi Ueno (University of Toyama) (作成者)
  • Yuki Miyajima (University of Toyama) (作成者)
  • Koyomi Kawago (寄稿者)
  • Ippei Sakamaki (寄稿者)
  • Yoshihiro Yamamoto (作成者)

データセット

説明

Additional file 2: Supplemental Figure 2. Dot plots represent the distribution of linezolid Cmin of the first measurement (first Cmin) at 12, 24, 36, or 48 h after starting administration of fixed 600 mg every 12 h in the RI group (A) and the non-RI group (B). Open circles represent Cmin 8 mg/L). Abbreviations: Cmin, trough concentration; fist Cmin, Cmin of first measurement; RI, renal impairment.
利用可能になった日2021
出版社figshare

引用スタイル